LENZ THERAPEUTICS, INC. Other Non-Current Liabilities
LENZ THERAPEUTICS, INC. (LENZ) had Other Non-Current Liabilities of $0 as of 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-03-19
- 2024-12-31: Other Liabilities, Noncurrent $0.00.
- 2024-09-30: Other Liabilities, Noncurrent $64.00K.
- 2024-06-30: Other Liabilities, Noncurrent $83.00K.
- 2024-03-31: Other Liabilities, Noncurrent $111.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-19 | |
| 2024-09-30 | $64.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $83.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $111.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $121.00K 10-K · filed 2025-03-19 | $0.00 10-K · filed 2024-02-27 |
| 2022-12-31 | $10.82M 10-K · filed 2024-02-27 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 | |
| 2021-09-30 | $64.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $64.00K 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $316.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |